Acrolein and the lung: Chemical, molecular, and pathological aspects

Advances in Molecular Toxicology

Volumn 4, Issue C, 2010, Pages 1-36

  Burcham, Philip C ^a   Thompson, Colin A ^a   Henry, Peter J ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACROLEIN; CYCLOOXYGENASE 2; CYCLOPHOSPHAMIDE; CYSTEINE; GLYCEROL; INTERLEUKIN 8; LYSINE;

AIRBORNE PARTICLE; BRONCHOSPASM; CELL DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOKINE PRODUCTION; CYTOTOXICITY; DNA DAMAGE; DOWN REGULATION; GENETIC TRANSCRIPTION; HUMAN; LUNG; LUNG BURN; LUNG CANCER; LUNG DISEASE; LUNG EDEMA; MUTAGENICITY; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN TARGETING; REVIEW; SUPRAMOLECULAR CHEMISTRY;

EID: 77954220298     PISSN: 18720854     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1872-0854(10)04001-4     Document Type: Review

References (151)

1. J.F. Stevens, C.S. Maier, Acrolein: Sources, metabolism, and biomolecular interactions relevant to human health and disease, Mol. Nutr. Food Res. 52 (2008) 7-25.
2. S.S. Hecht, Smoking and lung cancel?-a new role for an old toxicant? Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15725-15726.
3. R.M. Adibhatla, J.F. Hatcher, Lipid oxidation and peroxidation in CNS health and disease: From molecular mechanisms to therapeutic opportunities, Antioxid. Redox Signal. 12 (2010) 125-169.
4. Anonymous, Toxicological review of acrolein CAS No. 107-02-8, US EPA, EPA/ 635/R-03/003 (2003) 1-106.
5. T. Vermeire, Acrolein, Environmental Health Criteria 127 (1992), IPCS, WHO, Geneva.
6. L. Li, A. Holian, Acrolein: A respiratory toxin that suppresses pulmonary host defense, Rev. Environ. Health 13 (1998) 99-108.
7. T. Morikawa, Acrolein, formaldehyde, and volatile fatty acids from smouldering combustion, J. Combust. Toxicol. 3 (1976) 135-151.
8. J.P. Eiserich, A. van der Vliet, G.J. Handelman, B. Halliwell, C.E. Cross, Dietary antioxidants and cigarette smoke-induced biomolecular damage: A complex interaction, Am. J. Clin. Nutr. 62 (1995) 1490S-1500S.
9. E.I. Finkelstein, M. Nardini, A. van der Vliet, Inhibition of neutrophil apoptosis by acrolein: A mechanism of tobacco-related lung disease? Am. J. Physiol. Lung Cell Mol. Physiol. 281 (2001) L732-L739.
10. G.E. Hartzeil, Overview of combustion toxicology, Toxicology 115 (1996) 7-23.
11. A.S. Buist, M.A. McBurnie, W.M. Vollmer, S. Gillespie, P. Burney, D.M. Mannino, A.M. Menezes, S.D. Sullivan, T.A. Lee, K.B. Weiss, R.L. Jensen, G.B. Marks, A. Gulsvik, E. Nizankowska-Mogilnicka, BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study, Lancet 370 (2007) 741-750.
12. J.C. Hoqg, W. Timens, The pathology of chronic obstructive pulmonary disease, Annu. Rev. Pathol. 4 (2009) 435-459.
13. P.A. Kirkham, G. Spooner, C. Ffoulkes-Jones, R. Calvez, Cigarette smoke triggers macrophage adhesion and activation: Role of lipid peroxidation products and scavenger receptor, Free Radie. Biol. Med. 35 (2003) 697-710.
14. W. Ning, C.J. Li, N. Kaminski, C.A. Feghali-Bostwick, S.M. Alber, Y.P. Di, S.L. Otterbein, R. Song, S. Hayashi, Z. Zhou, D.J. Pinsky, S.C. Watkins, J.M, Pilewski, F.C. Sciurba, D.G. Peters, J.C. Hogg, A.M. Choi, Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary dsease, Proc. Natl. Acad. Sci. U. S. A, 101 (2004) 14895-14900.
15. P.R. Reynolds, M.G. Cosio, J.R. Hoidal, Cigarette smoke-induced Egr-1 upregulates proinflammatory cytokines in pulmonary epithelial cells, Am. J. Respir. Cell MoL Biol. 35 (2006) 314-319.
16. W. Ning, Y. Dong, J. Sun, C Li, M.A. Matthay, C.A. Feghali-Bostwick, A.M. Choi, Cigarette smoke stimulates matrix metalloproteinase-2 activity via EGR-I in human lung fibroblasts, Am. J. Respir. Cell MoI. Biol. 36 (2007) 480-490.
17. F.J. Kaye, Molecular biology of lung cancer, Lung Cancer 34 (Suppl. 2) (2001) S35-S41.
18. S.S. Hecht, Tobacco carcinogens, their biomarkers and tobacco-induced cancer, Nat. Rev. Cancer. 3 (2003) 733-744.
19. Z. Feng, W. Hu, Y. Hu, M.S. Tang, Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair, Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15404-15409.
20. P. Enkhbaatar, D.L. Traber, Pathophysiology of acute lung injury in combined burn and smoke inhalation injury, Clin. Sci. (Lond.). 107 (2004) 137-143. (Pubitemid 39070929)
21. R.H. Demling, Smoke inhalation lung injury: An update, Eplasty 8 (2008) e27.
22. D.M. Heimbach, J.F. Waeckerle, Inhalation injuries, Ann. Emerg. Med. 17 (1988) 1316-1320.
23. M.A. Matthay, H.G. Folkesson, C Clerici, Lung epithelial fluid transport and the resolution of pulmonary oedema, Physiol. Rev. 82 (2002) 569-600.
24. Y. Berthiaume, M.A. Matthay, Alveolar edema fluid clearance and acute lung injury, Respir. Physiol. Neurobiol. 159 (2007) 350-359. (Pubitemid 350123611)
25. P.C. Fuchs, E. Demir, K. Reuber, P. Stromps, T. Wolter, N. Pallua, Intra-alveolar IL-6 levels following burn and inhalation injury, Burns 35 (2009) 840-844.
26. B.A. Zikria, J.M. Ferrer, H.F. Floch, The chemical, factors contributing to pulmonary damage in "smoke poisoning", Surgery 71 (1972) 704-709.
27. C.A. Hales, P.W. Barkin, W. Jung, E. Trautman, D. Lamborghini, N. Herrig, J. Burke, Synthetic smoke with acrolein but not HCl produces pulmonary edema, J. Appl. Physiol. 64 (1988) 1121-1133.
28. O. Efimova, A.B. Volokhov, S. Iliaifar, CA. Hales, Ligation of the bronchial artery in sheep attenuates early pulmonary changes following exposure to smoke, J. Appl, Physiol. 88 (2000) 888-893.
29. C.A. Hales, S.W. Musto, S. Janssens, W. Jung, D.A. Quinn, M. Witten, Smoke aldehyde component influences pulmonary edema, J. Appl. Physiol. 72 (1992) 555-561.
30. J.M. Patel, Metabolism and pulmonary toxicity of cyclophosphamide, Pharmacol. Ther. 47 (1990) 137-146.
31. J.M. Patel, E.R. Block, CL. Hood, Biochemical indices of cyclophosphamideinduced lung toxicity, Toxicol. Appl. Pharmacol. 76 (1984) 128-138.
32. R.M. LoPachin, T. Gavin, D.R. Petersen, D.S. Barber, Molecular mechanisms of 4hydroxy-2-noneiial and acrolein toxicity: Nucleophilic targets and adduct formation, Chem. Res. Toxicol. 22 (2009) 1499-1508.
33. P.P. Guengerich, D.C. Liebler, Enzymatic activation of chemicals to toxic metabolites, Grit. Rev. Toxicol. 14 (1985) 259-307.
34. R.M. LoPachin, T. Gavin, B.C. Geohagen, S. Das, Neurotoxic mechanisms of electrophilic type-2 alkenes: Soft-soft interactions described by quantum mechanical parameters, Toxicol. Sci. 98 (2007) 61-570.
35. K. Ramu, C.S. Perry, T. Ahmed, G. Pakenham, J.P. Kehrer, Studies on the basis for the toxicity of acrolein mercapturates, Toxicol. Appl. Pharmacol. 140 (1996) 487-498.
36. H. Esterbauer, A. Ertl, N. Scholz, The reaction of cysteine with α,β-unsaturated aldehydes, Tetrahedron 32 (1976) 285-289.
37. J. Cai, A. Bhatnagar, W.M, Pierce, Jr, Protein modification by acrolein: Formation and stability of cysteine adducts, Chem. Res. Toxicol. 22 (2009) 708-716.
38. I. Dalle-Donne, M. Carini, G. Vistoli, L. Gamberoni, D. Giustarini, R. Colombo, R. Maffei Facino, R. Rossi, A, Milzani, G. Aldini, Actin-Cys374 as a nucleophilic target of α,β-unsaturated aldehydes, Free Radie. Biol. Med. 42 (2007) 583-598.
39. N.D. Horton, S.S. Biswal, L.L. Corrigan, J. Bratta, J.P. Kehrer, Acrolein causes inhibitor kB-independent decreases in nuclear factor kB activation in human lung adenocarcinoma (A549) cells, J. Biol. Chem. 274 (1999) 9200-9206.
40. L.J. Macpherson, A.E. Dubin, M.J. Evans, F. Marr, P.G. Schultz, B.F. Cravatt, A. Patapoutian, Noxious compounds activate TRPAl ion channels through covalent modification of cysteines, Nature 445 (2007) 541-545.
41. J.C. Kern, J.P. Kehrer, Acrolein-induced cell death: A caspase-influenced decision between apoptosis and oncosis/necrosis. Chem. Biol. Interact. 139 (2002) 79-95.
42. P.C. Burcham, A. Raso, C. Thompson, D. Tan, Intermolecular protein cross-linking during acrolein toxicity: Efficacy of carbonyl scavengers as inhibitors of heat shock protein-90 cross-linking in A549 cells, Chem, Res. Toxicol, 20 (2007) 1629-1637.
43. K. Uchida, M. Kanematsu, Y. Morimitsu, T. Osawa, N. Noguchi, E. Niki, Acrolein is a product of lipid peroxidation reaction. Formation of free acrolein and its conjugate with lysine residues in oxidized low density lipoproteins, J. Biol. Chem, 273 (1998) 16058-16066.
44. L.M. Kaminskas, S.M. Pyke, P.C. Burcham, Michael addition of acrolein to lysinyl and N-terminal residues of a model peptide: Targets for cytoprotective hydrazino drugs. Rapid Commun, Mass Spectrom. 21 (2007) 1155-1164.
45. A. Furuhata, M. Nakamura, T. Osawa, K. Uchida, Thiolation of protein-bound carcinogenic aldehyde. An electrophilic acrolein-lysine adduce that covalently binds to thiols, J. Biol. Chem. 277 (2002) 27919-27926.
46. T. Ishii, T. Yamada, T. Mori, S. Kumazawa, K. Uchida, T. Nakayama, Characterization of acrolein-induced protein cross-links, Free Radie. Res. 41 (2007) 1253-1260.
47. A. Furuhata, T. Ishii, S. Kumazawa, T. Yamada, T. Nakayama, K. Uchida, N(e)-(3methylpyridinium)lysine, a major antigenic addiict generated in acrolein-modified protein, J. Biol. Chem. 278 (2003) 48658-48665.
48. T. Obama, R, Kato, Y. Masuda, K, Takahashi, T. Aiuchi, H, Itabe, Analysis of modified apolipoprotein B-100 structures formed in oxidized low-density lipoprotein using LC-MS/MS, Proteomics 7 (2007) 2132-2141.
49. P.C. Burcham, L.M. Kaminskas, D. Tan, S.M. Pyke, Carbonyl-scavenging drugs & protection against carbonyl stress-associated cell injury, Mini Rev. Med, Chem. 8 (2008) 319-330.
50. D.J. Conklin, P. Haberzettl, R.A, Prough, A. Bhatnagar, Glutathione-S-transferase P protects against endothelial dysfunction induced by exposure to tobacco smoke, Am. J. Physiol. Heart Circ. Physiol, 296 (2009) H1586-H1597.
51. P.C. Burcham, F.R. Fontaine, D.R. Petersen, S.M. Pyke, Reactivity with Tris (hydroxymethyl)aminomethane confounds immunodetection of acrolein-adducted proteins, Chem. Res. Toxicol. 16 (2003) 1196-1201.
52. I. Dalle-Donne, M. Carini, G. Vistoli, L. Gamberoni, D. Giustarini, R. Colombo, R. Maffei Facino, R, Rossi, A. Milzani, G. Aldini, Actin-Cys374 as a nucleophilic target of a,ß-unsaturated aldehydes, Free Radie. Biol. Med. 42 (2007) 583-598.
53. C. Lambert, J. Li, K. Jonscher, T.C. Yang, P. Reigan, M. Quintana, J. Harvey, B.M. Freed, Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-KBl DNA binding domain, J. Biol, Chem, 282 (2007) 19666-19675.
54. R.A. Smith, D.S. Williamson, S.M, Cohen, Identification of 3,N" -propanodeoxycytidine 5′-monophosphate formed by the reaction of acrolein with deoxycytidine 5′-monophosphate, Chem. Res. Toxicol. 2 (1989) 267-271.
55. 32P-postlabeling, Cancer Res. 50 (1990) 3005-3012.
56. A. Chenna, R.A. Rieger, C.R. Iden, Characterization of thymidine adducts formed by acrolein and 2-bromoacrolein, Carcinogenesis 13 (1992) 2361-2365.
57. P.C. Burcham, Genotoxic lipid peroxidation products: Their DNA damaging properties and role in formation of endogenous DNA adducts, Mutagenesis 13 (1998) 287-305.
58. I.G. Minko, I.D. Kozekov, T.M. Harris, C.J. Rizzo, R.S. Lloyd, M.P. Stone, Chemistry and biology of DNA containing l,N(2)-deoxyguanosine adducts of the a,ß-unsaturated aldehydes acrolein, crotonaldehyde, and 4-hydroxynonenal, Chem, Res. Toxicol, 22 (2009) 759-778.
59. A. Emami, M. Dyba, A.K. Cheema, J. Pan, R.G. Nath, F.L. Chung, Detection of the acrolein-derived cyclic DNA adduce by a quantitative ' P-postlabeling/solid-phase extraction/HPLC method: Blocking its artifact formation with glutathione, Anal. Biochem. 374 (2008) 163-172.
60. 2- propanodeoxyguanosine adducts as potential endogenous DNA lesions in rodent and human tissues, Cancer Res. 56 (1996) 452-456.
61. 2-propanodeoxyguanosine adducts: Potential new biomarkers of smoking-induced DNA damage in human oral tissue, Cancer Res. 58 (1998) 581-584.
62. X. Liu, M.A. Lovell, B.C. Lynn, Development of a method for quantification of acrolein-deoxyguanosine adducts in DNA using isotope dilution-capillary LC/ MS/MS and its application to human brain tissue, Anal. Chem. 77 (2005) 5982-5989.
63. 2-propanodeoxyguanosine adducts in human lung by liquid chromatography-electrospray ionization-tandem mass spectrometry, Chem. Res. Toxicol. 20(2007)565-571.
64. S.G. Carmella, M. Chen, S. Han, A. Briggs, J. Jensen, D.K. Hatsukami, S.S. Hecht, Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers, Chem. Res. Toxicol. 22 (2009) 734-741.
65. P.C. Burcham, A. Raso, C.A. Thompson, Intermediate filament carbonylation during acute acrolein toxicity in A549 lung cells: Functional consequences, chaperone redistribution and protection by bisulfite, Antioxid. Redox Signal. 12 (2010) 337-347.
66. D.C. Liebler, Protein damage by reactive electrophiles: Targets and consequences, Chem, Res. Toxicol. 21 (2008) 117-128.
67. G. Valacchi, E. Pagnin, A. Phung, M. Nardini, B.C. Schock, C.E. Cross, A. van der Vliet, Inhibition of NFKB activation and IL-8 expression in human bronchial epithelial cells by acrolein, Antioxid. Redox Signal. 7 (2005) 25-31.
68. J.D. West, L.J. Marnett, Endogenous reactive intermediates as modulators of cell signaling and cell death, Chem.Res. Toxicol. 19 (2006) 173-194.
69. N. Mukaida, Pathophysiological roles of interleukin-8/CXCL8 in pulmonary diseases, Am. J. Physiol, Lung Cell Mol Physiol. 284 (2003) L566-L577. (Pubitemid 36343304)
70. C. Ji, K.R. Kozak, LJ. Marnett, 1KB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal, J. Biol. Chem, 276 (2001) 18223-18228. (Pubitemid 37411392)
71. L. Li, R.F. Hamilton, Jr, A. Holian, Effect of acrolein on human alveolar macrophage NF-KB activity, Am. j. Physiol. 277 (1999) L550-L557.
72. N.D. Horton, S.S. Biswal, L.L.. Corrigan, J. Bratta, J.P. Kehrer, Acrolein causes inhibitor KB-independent decreases in nuclear factor KB activation in human lung adenocarcinoma (A549) cells, J. Biol, Chem. 274 (1999) 9200-9206.
73. T. Kueper, T. Grune, S. Prahl, H, Lenz, W. Welge, T. Biernoth, Y. Vogt, G.M. Muhr, A, Gaemlich, T.Jung, G. Boemke, H.P. Elsässer, K.P. Wittern, H. Wenck, F. Stab, T. Blatt, Vimentin is the specific target in skin glycation: Structural prerequisites, functional consequences, and role in skin aging, J. Biol. Chem. 282 (2007) 23427-23436.
74. B.W. Meier, J.D. Gomez, A. Zhou, J.A. Thompson, Immunochemical and proteomic analysis of covalent adducts formed by quinone methide tumor promoters in mouse lung epithelial cell lines, Chem. Res. Toxicol. 18 (2005) 1575-1585.
75. 1 : Focus on vimentin, J. Mass Speetrom. 42 (2007) 1474-1484.
76. B.B. Oniary, Intermediate filaments and their associated diseases, N.Engl. J. Med. 351 (2004) 2087-2100.
77. M. Pekny, E.B. Lane, Intermediate filaments and stress, Exp. Cell Res. 313 (2007) 2244-2254.
78. H.K. Hamadeh, P.R. Bushel, S. Jayadev, O. DiSorbo, L. Bennett, L. Li, R. Tennant, R. Stoll, J.C. Barrett, R.S. Paules, K. Blanchard, C.A. Afshari, Prediction of compound signature using high density gene expression profiling, Toxicol. Sci. 67 (2002) 232-240.
79. J.F. Waring, R.A. Jolly, R. Ciurlionis, P.Y. Lum.J.T. Praestgaard, D.C. Morfitt, B. Buratto, C. Roberts, E. Schadt, R.G. Ulrich, Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles, Toxicol, Appl. Pharmacol. 175 (2001) 28-42.
80. L. Huang, A.N. Heinloth, Z.B. Zeng, R.S. Paules, P.R. Bushel, Genes related to apoptosis predict necrosis of the liver as a phenotype observed in rats exposed to a compendium of hepatotoxicants, BMC Genomics 9 (2008) 288.
81. W.O. Osbum, T.W. Kensler, Nrf2 signaling: An adaptive response pathway for protection against environmental toxic insults, Mutat. Res. 659 (2008) 31-39.
82. K. Itoh, K.I. Tong, M. Yamamoto, Molecular mechanism activating Nrf2-Keapl pathway in regulation of adaptive response to electrophiles, Free Radie. Biol, Med. 36 (2004) 1208-1213.
83. J.D. Hayes, M. McMahon, NRF2 and KEAP1 mutations: Permanent activation of an adaptive response in cancer, Trends Biochem. Sci. 34 (2009) 176-188.
84. R. Tirumalai, T. Rajesh Kumar, K.H. Mai, S. Biswal, Acrolein causes transcriptional induction of phase II genes by activation of Nrf2 in human lung type II epithelial. (A549) cells, Toxicol. Lett. 132 (2002) 27-36.
85. H. Zhang, H.J. Forman, Signaling pathways involved in. phase II gene induction by a,ß-unsaturated aldehydes, Toxicol. Ind. Health 25 (2009) 269-278.
86. J.P. Lyon, LJ. Jenkins, R.A. Jones, R.A. Coon, J. Siegel, Repeated and continuous exposure of laboratory animals to acroldn, Toxicol. Appl. Pharmacol. 17 (1970) 726-732.
87. H.S. Deshmukh, C Shaver, L.M. Case, M. Dietsch, S.C. Wesselkamper, W.D. Hardie, T.R. Korfhagen, M. Corradi, J.A. Nadel, M.T. Borchers, G.D. Leikauf, Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production, Am. J. Respir. Cell Mol. Biol. 38 (2008) 446-454.
88. H.S. Deshmukh, L.M. Case, S.C. Wesselkamper, M.T. Borchers, L.D. Martin, H.G. Shertzer, J.A, Nadel, G.D. Leikauf, Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation, Am. J. Respir. Crit. Care Med. 1.71 (2005) 305-314. (Pubitemid 40223396)
89. H.S. Deshmukh, C Shaver, L.M. Case, M. Dietsch, S.C. Wesselkamper, W.D. Hardie, T.R. Korfhagen, M. Corradi, J.A. Nadel, M.T. Borchers, G.D. Leikauf, Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production, Am, J. Respir. Cell Mol. Biol, 38 (2008) 446-454.
90. C.A. Thompson, P.C. Burcham, Genome-wide transcriptional, responses to acrolein, Chem. Res. Toxicol. 21 (2008) 2245-2256.
91. P.R. Reynolds, M.G. Cosio, J.R. Hoidal, Cigarette smoke-induced Egr-1 upregu-lates proinflammatory cytokines in. pulmonary epithelial, cells, Am, J. Respir. Cell. MoI. Biol, 35 (2006) 314-319.
92. W. Ning, Y. Dong, J. Sun, C. Li, M.A. Matthay, C.A. Feghali-Bostwick, A.M. Choi, Cigarette smoke stimulates matrix metalloproteinase-2 activity via EGR-I in human lung fibroblasts, Am. J. Respir. Cell Mol. Biol. 36 (2007) 480-490.
93. S. Grotegut, D. von Schweinitz, G. Christofori, F. Lehembre, Hepatocyte growth factor induces cell scattering through MAPK/Egr-1-mediated upregulation. of Snail, EMBOJ. 25 (2006) 534-545.
94. A. Kubosaki, Y. Tomaru, M. Tagami, E. Arner, H. Miura, T. Suzuki, M. Suzuki, H. Suzuki, Y. Hayashizaki, Genome-wide investigation of in vivo EGR-I binding sites in monocytic differentiation, Genome Biol. 1.0 (2009) R41.
95. S. Arora, Y. Wang, Z. Jia, S. Vardar-Sengul, A. Munawar, K.S. Doctor, M. Birrer, M, McClelland, E. Adamson, D. Mercola, Egrl regulates the coordinated expression. of numerous EGF receptor target genes as identified by ChIP-on-chip, Genome Biol, 9 (2008) R166.
96. B.T. Mossman, K.M. Lounsbury, S.P. Reddy, Oxidants and signaling by mitogen-activated protein kinases in lung epithelium, Am. J. Respir. Cell Mol. Biol. 34 (2006) 666-669. (Pubitemid 43825330)
97. A. Tanel, D.A. Averill-Bates, P38 and ERK mitogen-activated protein kinases mediate acrolein-induced apoptosis in Chinese hamster ovary cells, Cell Signal. 19 (2007)968-977.
98. N. Moretto, F. Facchinetti, T. Southworth, M Civelli, D. Singh, R. Patacchini, α,β-Unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases, Am. J. Physiol. Lung Cell Mol. Physiol. 296 (2009) L839-L848.
99. F. Facchinetti, F. Amadei, P. Geppetti, F. Tarantini, C. Di Serio, A. Dragotto, P.M. Gigli, S. Catinella, M. Civelli, R. Patacchini, αβ-unsaturated aldehydes in cigarette smoke release inflammatory mediators from human macrophages, Am. J. Respir. Cell Mol. Biol. 37 (2007) 617-623.
100. M. Parola, G. Robino, F. Marra, M. Pinzani, G. Bellomo, G. Leonarduzzi, P. Chiarugi, S. Camandola, G. Poli, G. Waeg, P. Gentium, M.U. Dianzani, HNE interacts directly with JNK isoforms in human hepatic stellate cells, J. Clin. Invest. 102 (1998) 1942-1950.
101. H. Kamata, S. Honda, S. Maeda, L. Chang, H. Hirata, M. Karin, Reactive oxygen. species promote TNFa-induced death and sustained. JNK activation by inhibiting MAP kinase phosphatases, Cell 120 (2005) 649-661.
102. D.R. Seiner, J.N. LaButti, K.S. Gates, Kinetics and mechanism of protein, tyrosine phosphatase IB inactivation by acrolein, Chem. Res. Toxicol. 20 (2007) 13151320.
103. C.A. Thompson, P.C. Burcham, Protein alkylation, transcriptional, responses and cytochrome c release during acrolein toxicity in A.549 cells: Influence of nucleophilic culture media constituents, Toxicol, In Vitro 22 (2008) 844-853.
104. R.A. Smith, S.M. Cohen, T.A. Lawson, Acrolein mutagenicity in the V79 assay Carcinogenesis 11 (1990) 497-498.
105. L.J. Marnett, H.K. Hurd, M.C. Hollstein, D.E. Levin, H. Esterbauer, B.N. Ames, Naturally occurring carbonyl compounds are mutagens in Salmonella tester strain TA104 Mutat. Res. 148 (1985) 25-34.
106. R.D. Curren, L.L.Yang, P.M. Conklin, R.C. Grafstrom, C.C. Harris, Mutagenesis of xeroderma pigmentosum fibroblasts by acrolein, Mutat. Res. 209 (1988) 17-22.
107. M. Kawanishi, T. Matsuda, A. Nakayama, H. Takebe, S. Matsui, T. Yagi, Molecular analysis of mutations induced by acrolein in human fibroblast cells using sup F shuttle vector plasmids, Mutat. Res. 417 (1998) 65-73.
108. L.A. VanderVeen, M.P. Hashim, L.V. Nechev, T.M. Harris, C.M. Harris, L.J. Marnett, Evaluation of the mutagenic potential of the principal DNA adduct of acrolein, J. Biol. Chem, 276 (2001) 9066-9070. (Pubitemid 37385485)
109. I.Y. Yang, M. Hossain, H. Miller, S. Khullar, F. Johnson, A. Grollman, M. Moriya, Responses to the major acrolein-derived deoxyguanosine adduct in Escherichia, coli, J. Biol, Chem, 276 (2001) 9071-9076.
110. M. Kanuri, I.G. Minko, L.V. Nechev, T.M. Harris, CM. Harris, R.S. Lloyd, Error prone translesion synthesis past γ-hydroxy-propanodeoxyguanosine, the primary acro-lein-derived adduct in mammalian cells, J. Biol. Chem. 277 (2002) 18257-18265.
111. S.I. Kim, G.P. Pfeifer, A. Besaratmia, Lack of mutagenicity of acrolein-induced DNA adducts in mouse and human cells, Cancer Res. 67 (2007) 11640-11647.
112. H.T. Wang, S. Zhang, Y. Hu, M.S. Tang, Mutagenicity and sequence specificity of acrolein-DNA adducts, Chem. Res. Toxicol, 22 (2009) 511-517.
113. P.C. Burcham, L.A. Harkin, Mutations at G:C base pairs predominate after replication, of peroxyl radical-damaged pSP189 plasmids in human cells, Mutagenesis 1.4 (1999) 135-140.
114. A. Besaratioia, Acrolein: Excessive cytotoxicity or potent mutagenicity? Chem. Res. Toxicol, 22 (2009) 751-753.
115. H.T. Wang, M.S. Tang, Acrolein, adducts are mutagenic, Chem. Res. Toxicol. 22 (2009) 753-754.
116. J.P. Kehrer, S.S. Biswal, The molecular effects of acrolein, Toxicol. Sci, 57 (2000) 6-15.
117. A. Tanel, D.A. Averill-Bates, The aldehyde acrolein induces apoptosis via activation of the mitochondrial pathway, Biochim. Biophys. Acta 1743 (2005) 255-267.
118. A. Tanel, D.A. Averill-Bates, Activation of the death, receptor pathway of apoptosis by the aldehyde acrolein, Free Radie. Biol, Med. 42 (2007) 798-810. (Pubitemid 46316775)
119. J. Roy, P. Pallepati, A. Bettaieb, A. Tanel, D.A. Averill-Bates, Acrolein induces a cellular stress response and triggers mitochondrial apoptosis in A549 cells, Chem. Biol. Interact. 181 (2009) 154-167.
120. U.M. Moll, N. Marchenko, X. Zhang, p53 and Nur77/TR3-transcription factors that directly target mitochondria for cell death, induction, Oncogene 25 (2006) 4725-4743.
121. B. Liang, X. Song, G. Liu, R, Li, J. Xie, L. Xiao, M. Du, Q. Zhang, X. Xu, X. Gan, D. Huang, Involvement of TR3/Nur77 translocation to the endoplasmic reticulum in ER stress-induced apoptosis, Exp. Cell Res. 313 (2007) 2833-2844.
122. S.O. Kim, K. Ono, P.S. Tobias, J. Han, Orphan nuclear receptor Nur77 is involved in caspase-independent macrophage cell death, J. Exp. Med. 197 (2003) 1441-1452.
123. S. Chintharlapalli, R. Burghardt, S. Papineni, S. Ramaiah, K. Yoon, Safe, Activation of Nur77 by selected 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)niethanes induces apoptosis through nuclear pathways, J. Biol. Chem, 280 (2005) 24903-24914.
124. L.Y. Lee, Respiratory sensations evoked by activation of bronchopulmonary C-fibers, Respir. Physiol. Neurobiol, 167 (2009) 26-35.
125. G.D. Leikauf, L.M. Leming, J.R. O'Donnell, CA. Doupnik, Bronchial responsiveness and inflammation in guinea pigs exposed to acrolein, J. Appl. Physiol. 66 (1989) 171-178.
126. C.R. Turner, R.B. Stow, S.D. Talerico, E.P. Christian, J.C. Williams, Protective role for neuropeptides in acute pulmonary response to acrolein in guinea pigs, J. Appl. Physiol, 75 (1993) 2456-2465.
127. E. Andre, B. Campi, S. Materazzi, M. Trevisani, S. Amadesi, D. Massi, C. Creminon, N. Vaksman, R. Nassini, M. Civelli, P.G. Baraldi, D.P. Poole, N.W. Bunnett, P. Geppetti, R. Patacchini, Cigarette smoke-induced neurogenic inflammation is mediated by α,β-unsaturated aldehydes and the TRPA1 receptor in rodents, J. Clin. Invest. 118 (2008) 2574-2582.
128. D.M. Bautista, S.E. Jordt, T. Nikai, P.R. Tsuruda, A.J. Read, J. Poblete, E.N. Yamoah, A.I. Basbaum, D. Julius, TRPA1 mediates the inflammatory actions of environmental irritants and proalgesic agents, Cell 124 (2006) 1269-1282.
129. A. Ben-jebria, Y. Crozet, M.L. Eskew, B.L. Rudeen, J.S. Ultman, Acrolein-induced smooth, muscle hyperresponsiveness and eicosanoid release in excised ferret tracheae, Toxicol. Appl. Pharmacol. 135 (1995) 35-44.
130. A. Ben-jebria, R. Marthan, M. Rossetti, J.P. Savineau, J.S. Ultman, Human bronchial smooth muscle responsiveness after in vitro exposure to acrolein, Am. J. Respir. Crit. Care Med. 149 (1994) 382-386. (Pubitemid 24068984)
131. A. Ben-jebria, R. Marthan, M. Rossetti, J.P. Savineau, J. S. Ultman, Effect of in vitro exposure to acrolein on carbachol responses in rat traehealis muscle, Respir. Physiol. 93 (1993) 111-123.
132. E. Roux, N. Ouedraogo, J.M. .Hyvelin, J.P. Savineau, R. Marthan, In vitro effect of air pollutants on human bronchi, Cell Biol. Toxicol. 1.8 (2002) 289-299.
133. J.M. Hyvelin, J.P. Savineau, R. Marthan, Selected contribution: Effect of the aldehyde acrolein on acetylcholine-induced membrane current in airway smooth muscle cells, J. Appl. Physiol. 90 (2001) 750-754.
134. J.M. Hyvelin, E. Roux, M.C. Prévost, J.P. Savineau, R. Marthan, Cellular mechanisms of acrolein-induced alteration in calcium signaling in airway smooth muscle, Toxicol. Appl. Pharmacol. 164 (2000) 176-183. (Pubitemid 30238537)
135. C.A. Doupnik, G.D. Leikauf, Acrolein stimulates eicosanoid release from bovine airway epithelial cells, Am. J. Physiol. 259 (1990) L222-L229.
136. P.M. Joseph, M.L. Witten, C.H. Burke, C.A. Hales, The effects of chronic sidestream cigarette smoke exposure on eicosanoid production by tracheal, epithelium, Exp. Lung Res. 22 (1996) 317-335.
137. C.A. Martey, S.J. Pollock, C.K. Turner, K.M. O'Reilly, C.J. Baglole, R.P. Phipps, P.J. Sime, Cigarette smoke induces cyclooxygenase-2 and microsomal, prostaglandin E2 synthase in human lung fibroblasts: Implications for lung inflammation and cancer, Am. J. Physiol. Lung Cell Mol Physiol. 287 (2004) L981-L991.
138. C.C. Grundfest, J. Chang, D. Newcombe, Acrolein: A potent modulator of lung macrophage arachidonic acid metabolism, Biochim. Biophys. Acta 713 (1982) 149159.
139. K.A. Berry, P.M. Henson, R.C. Murphy, Effects of acrolein on leukotriene biosynthesis in human neutrophils, Chem, Res. Toxicol. 21 (2008) 2424-2432.
140. Y.S. Park, J. Kim, Y. Misonou, R. Takamiya, M. Takahashi, M.R. Freeman, N. Taniguchi, Acrolein induces cydooxygenase-2 and prostaglandin production in human umbilical vein endothelial, cells: Roles of p38 MAP kinase, Arterioscler. Thromb. Vase. Biol. 27 (2007) 1319-1325.
141. P. Sarkar, B.E. Hayes BE, Induction of COX-2 by acrolein in rat lung epithelial cells, Mol. Cell Biochem, 301 (2007) 191-199.
142. +-dependent 15-hydroxyprostaglandin dehydrogenase by acrolein, Biochem, Pharmacol, 34 (1985) 4275-4278.
143. 2, Trends Immunol. 25 (2004) 40-46.
144. 2 (PAR2)-prostaglandin E2-prostanoid EP receptor axis: A potential bronchoprotective unit in the respiratory tract? Eur. J. Pharmacol. 533 (2006) 156-170.
145. 2 on airway tone, Am. J. Physiol, Lung Cell Mol. Physiol. 284 (2003) L599-L606.
146. T.E. Taylor-Clark, B.J. Undem, D.W. Maeglashan, S. Ghatta, M.J. Carr, M.A. McAlexander, Prostaglandin-induced activation of nociceptive neurons via direct interaction with transient receptor potential Al. (TRPAl), Mol. Pharmacol. 73 (2008) 274-281.
147. 2 receptor activation, J. Cell Physiol. 210(2007)99-110.
148. A. Kawabata, S. Kubo, T. Ishiki, N. Kawao, F. Sekiguchi, R. Kuroda, M.D. Hollenberg, T. Kanke, N. Saito, Proteinase-activated receptor-2-mediated relaxation in mouse tracheal and bronchial smooth muscle: Signal transduction mechanisms and distinct agonist sensitivity, J. Pharmacol, Exp. Ther. 311 (2004) 402-410.
149. 2 formation in human lung epithelial cells, J. Pharmacol. Exp. Ther. 315 (2005) 576-589.
150. S. Hazra, K.A. Peebles, S. Sharma, J.T. Mao, S.M. Dubinett, The role of PPAR7 in the cyclooxygenase pathway in lung cancer, PPAR Res. 2008 (2008) 790568.
151. J.M. Lee, J. Yanagawa, K.A. Peebles, S. Sharma, J.T. Mao, S.M. Dubinett, Inflammation in lung carcinogenesis: New targets for lung cancer chemoprevention and treatment, Crit. Rev. Oncol. Hematol. 66 (2008) 208-217.